Gene Therapy
Base Excision Repair
In-vitro Mutagenesis
Nucleotide Excision Repair
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 29, 2026
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Alain Fischer1
1Imagine Institute, Hôpital Necker-Enfants Malades, Paris 75015, France, and at the Collège de France, Paris.
No abstract available in PubMed .
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
Published on: March 12, 2018
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023